ADMA Biologics Inc vs Verizon Communications Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Verizon Communications Inc trades at $47.13 (market cap $196.40B). The key difference: Verizon Communications Inc is far larger — about 88.5× ADMA Biologics Inc's market cap, and Verizon Communications Inc pays a 5.99% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | VZ | |
|---|---|---|
Market Cap | $2.22B | $196.40B |
Sector | Health | Media |
52-Week High | $20.38 | $51.38 |
52-Week Low | $7.60 | $38.40 |
Enterprise Value | $2.29B | $383.10B |
Volume | — | 22,584,735 |
Dividend Yield | — | 5.99% |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →